Acurx Pharmaceuticals, Inc…received a positive opinion from the European Medicines Agency’s Paediatric Committee (PDCO) on its Pediatric Investigation Plan (PIP) for ibezapolstat in treating children with Clostridioides difﬁcile infection (CDI)